(FM) Medicina Interna
Departamento académico
University of Tübingen
Tubinga, AlemaniaPublicaciones en colaboración con investigadores/as de University of Tübingen (6)
2024
-
Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3
Biomedicine and Pharmacotherapy, Vol. 180
2022
-
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Clinical Cancer Research, Vol. 28, Núm. 12, pp. 2555-2566
-
Prognostic Factors for Effectiveness Outcomes After Transarterial Radioembolization in Metastatic Colorectal Cancer: Results From the Multicentre Observational Study CIRT
Clinical Colorectal Cancer, Vol. 21, Núm. 4, pp. 285-296
2019
-
Corrigendum to “New vaccination strategies in liver cancer” [Cytokine Growth Factor Rev. 36 (2017) 125–129](S1359610117301089)(10.1016/j.cytogfr.2017.06.010)
Cytokine and Growth Factor Reviews
-
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
Genome Medicine, Vol. 11, Núm. 1
2015
-
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey
Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9